Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC72991 (Rac)-Lisaftoclax

    (Rac)-APG-2575

    (Rac)-LisaftoclaxRac-APG-2575是一种Bcl-2抑制剂,可用于血液恶性肿瘤研究CN112898295A。
  3. GC72985 Z-LEVD-FMK Z-LEVD-FMK是一种细胞渗透性caspase-4抑制剂。
  4. GC72971 INCB3619 INCB3619ADAM10和ADAM17的IC50分别为22nM和14nM。
  5. GC72944 MMRi64 MMRi64破坏Mdm2-MdmX相互作用。
  6. GC72933 LQZ-7F LQZ-7F是一种survivin二聚化抑制剂,在前列腺癌细胞中诱导自发凋亡并与多西他赛协同作用。
  7. GC72931 HTH-01-091 TFA HTH-01-091 TFA是一种有效的、选择性的母胚亮氨酸拉链激酶(MELK)抑制剂,IC50为10.5 nM。
  8. GC72929 DB818 dihydrochloride DB818 dihydrochloride是DB818的二氯盐形式。
  9. GC72928 DB818 DB818是homobox A9 (HOXA9)的有效抑制剂。
  10. GC72924 PD173952 PD173952是一种酪氨酸激酶抑制剂,对Lyn、Abl和Csk的ic50分别为0.3、1.7和6.6 nM。
  11. GC72915 (R)-MRT199665 (R)-MRT199665是MRT199665的异构体。
  12. GC72910 DD1 DD1蛋白酶体抑制剂,靶向急性髓系白血病(AML)凋亡过程中Bax的激活和P70S6K的降解。
  13. GC72892 Oblimersen sodium Oblimersen sodium是一种针对BCL-2 RNA的BCL-2抑制剂。
  14. GC72878 UCD38B hydrochloride UCD38B hydrochloride是一种细胞渗透的竞争性酶促uPA抑制剂,IC50值为7 μM。
  15. GC72875 Justicidin A Justicidin A是一种天然产物,可以从Justicia procumbens中分离出来。
  16. GC72868 AZA197 AZA197是Cdc42的选择性小分子抑制剂。
  17. GC72864 PZ703b hydrochloride PZ703b hydrochloride是一种Bcl-xl PROTAC降解剂,可诱导细胞凋亡,抑制癌细胞增殖。
  18. GC72863 PZ703b TFA PZ703b TFA是一种Bcl-xl PROTAC降解剂,诱导细胞凋亡,抑制癌细胞增殖,用于膀胱癌研究。
  19. GC72862 Erasin Erasin是一种强效的厄洛替尼抗性拮抗STAT3抑制剂,对STAT3和STAT1的IC50分别为9.7和24μM。
  20. GC72858 Avenanthramide A Avenanthramide A是一种可以在燕麦(Avena sativa L)。
  21. GC72851 Belapectin

    GR-MD-02

    Belapectin (GR-MD-02)是半乳糖凝集素-3 (Gal-3)抑制剂。
  22. GC72835 NSC260594 NSC260594诱导细胞凋亡。
  23. GC72824 KX2-361

    KX-02

    KX2-361(KX-02)是一种Src激酶和微管蛋白聚合抑制剂。
  24. GC72817 BAI1 hydrochloride BAI1 hydrochloride是一种选择性凋亡因子BAX变构抑制剂。
  25. GC72803 Aspidin BB Aspidin BB是一种间苯三酚衍生物,可从冠毛鳞毛蕨的地上部分分离得到。
  26. GC72792 Cyclopentenylcytosine

    CPEC; NSC 375575

    Cyclopentenylcytosine(CPC)是一种核苷类似物,通过抑制CTP合成酶来降低白血病细胞中胞苷三磷酸(CTP)和脱氧胞苷三磷酸盐(dCTP)的水平。
  27. GC72791 Delmitide acetate

    RDP-58 acetate

    Delmitide acetate是一种口服活性d-异构体十肽,具有强效抗炎活性。
  28. GC91820 PDIC-NS PDIC-NS is an activator of stimulator of interferon genes (STING).
  29. GC91782 DPP-9 Inhibitor 42

    Dipeptidyl Peptidase 9 Inhibitor 42

    DPP-9 inhibitor 42 is an inhibitor of dipeptidyl peptidase 9 (DDP-9; IC50 = 0.0034 µM).
  30. GC91688 PDIC-NN PDIC-NN is an intermediate in the synthesis of PDIC-NS , an activator of stimulator of interferon genes (STING) with anticancer activity.
  31. GC91595 PDIC-NC PDIC-NC is an activator of stimulator of interferon genes (STING) and an anticancer agent.
  32. GC72575 L-Glutamic acid monosodium (hydrate) L-Glutamic acid monosodium (hydrate)是一种营养添加剂和调味剂。
  33. GC72511 L-Cystathionine dihydrochloride L-Cystathionine dihydrochloride是一种非蛋白硫醚,是与含硫氨基酸代谢状态相关的关键氨基酸。
  34. GC72463 Rulonilimab Rulonilimab是一种针对PD-1的人IgG1单克隆抗体,其靶向、结合并抑制PD-1及其下游信号通路。
  35. GC72440 Ozoralizumab Ozoralizumab (ATN-103)是一种抗tnf α人源化抗体。
  36. GC72423 Letolizumab Letolizumab (BMS-986004)是一种靶向CD40L的单克隆抗体,其产生是为了表达缺乏效应功能的突变体IgG1,包括Fc结合和补体固定。
  37. GC72419 Iscalimab Iscalimab(CFZ-533)是一种靶向CD40的非耗竭性IGg1单克隆抗体(KD:0.3nM)。
  38. GC72386 Afelimomab Afelimomab(MAK 195F)是一种抗肿瘤坏死因子F(ab')2单克隆抗体片段。
  39. GC72378 Neihulizumab Neihulizumab(ALTB-168)是一种免疫检查点激动性抗体,与人CD162(PSGL-1)结合,导致活化T细胞下调。
  40. GC72365 Visilizumab Visilizumab(抗人CD3E重组抗体)是一种人源化低Fc受体结合的抗CD3单克隆IgG2抗体。
  41. GC72364 Toralizumab Toralizumab(IDEC-131)是一种针对CD40L(CD154)的人源化单克隆抗体(mAb),由人γ1重链和人κ轻链组成。
  42. GC72360 Ruplizumab Ruplizumab(BG 9588)是一种人源化单克隆抗CD40L(TNF受体)IgG1κ抗体。
  43. GC72359 Quilizumab Quilizumab(抗人NGcGM3重组抗体)是一种人源化IgG1κ单克隆抗体。
  44. GC72337 Anti-Mouse 4-1BB/CD137 Antibody (3H3) Anti-Mouse 4-1BB/CD137 Antibody (3H3)是来源于宿主大鼠的抗小鼠4-1BB IgG2a抗体抑制剂。
  45. GC72319 Atrosab Atrosab是一种人源化IgG1拮抗性抗TNFR1抗体。
  46. GC72318 Tulisokibart Tulisokibart (PRA023)是一种人源化IgG1-κ单克隆抗体,靶向TNFSF15/TL1A。
  47. GC72251 Tripeptide-32 Tripeptide-32是一种具有抗衰老作用的生物活性肽,已被报道用作化妆品成分。
  48. GC72216 (Gly14)-Humanin (human) (acetate) (Gly14)-Humanin (human) (acetate)是Humanin的类似物,其中第14个氨基酸丝氨酸被甘氨酸(Gly)取代。
  49. GC72191 Pep19-2.5 Pep19-2.5是一种合成的抗毒素肽,阻断细胞内内毒素信号级联。
  50. GC72186 WLSEAGPVVTVRALRGTGSW WLSEAGPVVTVRALRGTGSW是一种心肌细胞特异性肽。
  51. GC72183 [D-Leu-4]-OB3 [D-Leu-4]-OB3抑制促炎、增殖和转移基因的表达以及pd - l1的表达。

Items 201 to 250 of 2733 total

per page
  1. 3
  2. 4
  3. 5
  4. 6
  5. 7

Set Descending Direction